SlideShare ist ein Scribd-Unternehmen logo
1 von 5
Find Industry reports, Company profiles
ReportLinker                                                                          and Market Statistics



                                               >> Get this Report Now by email!

Genentech, Inc. - Financial and Strategic Analysis Review
Published on June 2009

                                                                                                                  Report Summary

Genentech, Inc. - Financial and Strategic Analysis Review


Summary


Genentech, Inc. (Genentech) is a biotechnology company focused on research and development, manufacturing, and marketing of
biotherapeutics. Genentech is developing the drugs across the unmet medical needs in cancer, asthma and angiogenic disorders.
Major focus of Genentech is on three areas namely; oncology, immunology, and tissue growth and repair. The company is
headquartered at South San Francisco in California, Unites States. Genentech is acquired by Roche in March 26, 2009. With this
acquisition, the company became the wholly owned subsidiary of the Roche Group.


Global Markets Direct's Genentech, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial
analysis of Genentech, Inc.. The report provides a comprehensive insight into the company, including business structure and
operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company.
This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.


Scope


- Provides key company information for business intelligence needs.
- The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational
factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are
highlighted.
- The report contains critical company information ' business structure and operations, the company history, major products and
services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.


Reasons to buy


- A quick 'one-stop-shop' to understand the company.
- Enhance business/sales activities by understanding customers' businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers ' with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company's financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.




Genentech, Inc. - Financial and Strategic Analysis Review                                                                          Page 1/5
Find Industry reports, Company profiles
ReportLinker                                                       and Market Statistics




                                                                                  Table of Content




Table Of Contents


Table Of Contents 2
List of Tables 3
List of Figures 3
Genentech, Inc. - Key Facts 4
Genentech, Inc. - Business Description 4
Genentech, Inc. - Major Products and Services 5
Genentech, Inc. - History 6
Genentech, Inc. - SWOT Analysis 8
SWOT Analysis - Overview 8
Genentech, Inc. - Strengths 8
Strength - Expanding Operating Margin 8
Strength - Strong Liquidity Position 8
Strength - Increased Product Sales 8
Strength - Sturdy Research and Development Activities 8
Strength - Performance of Oncology Products 8
Strength - Patent Protection on Key Products 8
Genentech, Inc. - Weaknesses 8
Weakness - Concentrated Revenues 8
Weakness - Limited Customer Base 9
Genentech, Inc. - Opportunities 9
Opportunity - Product Pipeline 9
Opportunity - Growing Global Oncology Market 9
Opportunity - Emerging Markets 9
Opportunity - Rising Healthcare Expenditure in the US 9
Opportunity - Changing Demographics 9
Genentech, Inc. - Threats 10
Threat - Generic Cancer Drugs 10
Threat - Industry Consolidation 10
Threat - Tightening of the FDA's Regulatory Oversight 10
Threat - Increased Pricing Control 10
Genentech, Inc. - Key Competitors 11
Genentech, Inc. - Key Employees 11
Genentech, Inc. - Key Employee Biographies 12
Genentech, Inc. - Company Statement 13
Genentech, Inc. - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Genentech, Inc. - Financial Ratios 16
Financial Ratios - Capital Market Ratios 16
Financial Ratios - Annual Ratios 16
Financial Ratios - Interim Ratios 17


Genentech, Inc. - Financial and Strategic Analysis Review                                     Page 2/5
Find Industry reports, Company profiles
ReportLinker                                                       and Market Statistics


Financial Ratios - Ratio Charts 18
Appendix 19
Methodology 19
Ratio Definitions 19
About Global Markets Direct 22
Contact Us 22
Disclaimer 22



List of Tables


Genentech, Inc., Key Facts 4
Genentech, Inc., Major Products and Services 5
Genentech, Inc., History 6
Genentech, Inc., Key Employees 11
Genentech, Inc., Key Employee Biographies 12
Genentech, Inc., Other Locations 15
Genentech, Inc., Ratios based on current share price 16
Genentech, Inc., Annual Ratios 16
Genentech, Inc., Interim Ratios 17



List of Figures


Genentech, Inc., Ratio Charts 18




Genentech, Inc. - Financial and Strategic Analysis Review                                     Page 3/5
Find Industry reports, Company profiles
ReportLinker                                                                             and Market Statistics


              Fax Order Form
              To place an order via fax simply print this form, fill in the information below and fax the completed form to:
                           Europe, Middle East and Africa : + 33 4 37 37 15 56
                           Asia, Oceania and America : + 1 (805) 617 17 93
              If you have any questions please visit http://www.reportlinker.com/notify/contact


              Order Information
              Please verify that the product information is correct and select the format(s) you require.

                    Genentech, Inc. - Financial and Strategic Analysis Review




              Product Formats
              Please select the product formats and the quantity you require.




                                    Digital Copy--USD 125.00                Quantity: _____




              Contact Information
              Please enter all the information below in BLOCK CAPITALS


              Title:                    Mr                  Mrs        Dr                Miss               Ms                 Prof

              First Name:                    _____________________________ Last Name: __________________________________

              Email Address:                __________________________________________________________________________

              Job Title:                    __________________________________________________________________________

              Organization:                 __________________________________________________________________________

              Address:                      __________________________________________________________________________

              City:                         __________________________________________________________________________

              Postal / Zip Code:             __________________________________________________________________________

              Country:                      __________________________________________________________________________

              Phone Number:                 __________________________________________________________________________

              Fax Number:                   __________________________________________________________________________




Genentech, Inc. - Financial and Strategic Analysis Review                                                                             Page 4/5
Find Industry reports, Company profiles
ReportLinker                                                                                       and Market Statistics


              Payment Information
              Please indicate the payment method, you would like to use by selecting the appropriate box.




                      Payment by credit card                      Card Number: ______________________________________________


                                                                  Expiry Date     __________ / _________


                                                                  CVV Number _____________________


                                                                  Card Type (ex: Visa, Amex…) _________________________________




                      Payment by wire transfer                    Crédit Mutuel
                                                                  RIB : 10278 07314 00020257701 89
                                                                  BIC : CMCIFR2A
                                                                  IBAN : FR76 1027 8073 1400 0202 5770 189




                       Payment by check                           UBIQUICK SAS
                                                                  16 rue Grenette – 69002 LYON, FRANCE




                                    Customer signature:

                                     




              Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
              http://www.reportlinker.com/index/terms




                                                                   Please fax this form to:

                                                            Europe, Middle East and Africa : + 33 4 37 37 15 56

                                                             Asia, Oceania and America : + 1 (805) 617 17 93




Genentech, Inc. - Financial and Strategic Analysis Review                                                                         Page 5/5

Weitere ähnliche Inhalte

Andere mochten auch

Roche holding AG: Genentech Acquisition
Roche holding AG: Genentech AcquisitionRoche holding AG: Genentech Acquisition
Roche holding AG: Genentech AcquisitionAmara Fatima
 
Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2heba rashed
 
How to create 360 images with google street view app
How to create 360 images with google street view app How to create 360 images with google street view app
How to create 360 images with google street view app proyectoste
 
السيرة الذاتيــــــــــــة
السيرة الذاتيــــــــــــةالسيرة الذاتيــــــــــــة
السيرة الذاتيــــــــــــةMahamat Ibrahim Kale
 

Andere mochten auch (7)

Roche holding AG: Genentech Acquisition
Roche holding AG: Genentech AcquisitionRoche holding AG: Genentech Acquisition
Roche holding AG: Genentech Acquisition
 
Pinizsi_portfolio_2
Pinizsi_portfolio_2Pinizsi_portfolio_2
Pinizsi_portfolio_2
 
Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2
 
How to create 360 images with google street view app
How to create 360 images with google street view app How to create 360 images with google street view app
How to create 360 images with google street view app
 
Phenol & it's Compounds
Phenol & it's Compounds Phenol & it's Compounds
Phenol & it's Compounds
 
السيرة الذاتيــــــــــــة
السيرة الذاتيــــــــــــةالسيرة الذاتيــــــــــــة
السيرة الذاتيــــــــــــة
 
CV
CVCV
CV
 

Mehr von ReportLinker.com

Smartphones: When is the first and last time you check yours?
Smartphones: When is the first and last time you check yours?Smartphones: When is the first and last time you check yours?
Smartphones: When is the first and last time you check yours?ReportLinker.com
 
Interview Co-Founder ReportLinker and Findout, Benjamin Carpano
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoInterview Co-Founder ReportLinker and Findout, Benjamin Carpano
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoReportLinker.com
 
Tutorial for the ReportLinker App
Tutorial for the ReportLinker AppTutorial for the ReportLinker App
Tutorial for the ReportLinker AppReportLinker.com
 
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
 
Global Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryGlobal Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryReportLinker.com
 
Global Wireless Gaming Industry
Global Wireless Gaming IndustryGlobal Wireless Gaming Industry
Global Wireless Gaming IndustryReportLinker.com
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
 
The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
 
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
 
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013ReportLinker.com
 
China iron ore mining industry, 2013
China iron ore mining industry, 2013China iron ore mining industry, 2013
China iron ore mining industry, 2013ReportLinker.com
 

Mehr von ReportLinker.com (20)

Smartphones: When is the first and last time you check yours?
Smartphones: When is the first and last time you check yours?Smartphones: When is the first and last time you check yours?
Smartphones: When is the first and last time you check yours?
 
Interview Co-Founder ReportLinker and Findout, Benjamin Carpano
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoInterview Co-Founder ReportLinker and Findout, Benjamin Carpano
Interview Co-Founder ReportLinker and Findout, Benjamin Carpano
 
Tutorial for the ReportLinker App
Tutorial for the ReportLinker AppTutorial for the ReportLinker App
Tutorial for the ReportLinker App
 
Samsung customer loyalty
Samsung customer loyaltySamsung customer loyalty
Samsung customer loyalty
 
Project Caf
Project CafProject Caf
Project Caf
 
Project Caf
Project CafProject Caf
Project Caf
 
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
 
 
 
Thisisatest
ThisisatestThisisatest
Thisisatest
 
Global Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryGlobal Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes Industry
 
Global Wireless Gaming Industry
Global Wireless Gaming IndustryGlobal Wireless Gaming Industry
Global Wireless Gaming Industry
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013
 
The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...
 
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
 
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
 
China iron ore mining industry, 2013
China iron ore mining industry, 2013China iron ore mining industry, 2013
China iron ore mining industry, 2013
 

Kürzlich hochgeladen

Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfSourav Sikder
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Onlinelng ths
 
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptxHELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptxHelene Heckrotte
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinAnton Skornyakov
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Lviv Startup Club
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfAnhNguyen97152
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsP&CO
 
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...TalentView
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGlokeshwarmaha
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsyasinnathani
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Reportamberjiles31
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examplesamberjiles31
 
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...Khaled Al Awadi
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...Brian Solis
 
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfAMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfJohnCarloValencia4
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access
 
Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Winbusinessin
 
Lecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toLecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toumarfarooquejamali32
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBBPMedia1
 

Kürzlich hochgeladen (20)

Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Online
 
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptxHELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup Berlin
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizations
 
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story points
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Report
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examples
 
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
 
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfAMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024
 
Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024
 
Lecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toLecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb to
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
 

Genentech, Inc. - Financial and Strategic Analysis Review

  • 1. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Genentech, Inc. - Financial and Strategic Analysis Review Published on June 2009 Report Summary Genentech, Inc. - Financial and Strategic Analysis Review Summary Genentech, Inc. (Genentech) is a biotechnology company focused on research and development, manufacturing, and marketing of biotherapeutics. Genentech is developing the drugs across the unmet medical needs in cancer, asthma and angiogenic disorders. Major focus of Genentech is on three areas namely; oncology, immunology, and tissue growth and repair. The company is headquartered at South San Francisco in California, Unites States. Genentech is acquired by Roche in March 26, 2009. With this acquisition, the company became the wholly owned subsidiary of the Roche Group. Global Markets Direct's Genentech, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Genentech, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward. Scope - Provides key company information for business intelligence needs. - The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered. - The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted. - The report contains critical company information ' business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries. - The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters. - Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios. Reasons to buy - A quick 'one-stop-shop' to understand the company. - Enhance business/sales activities by understanding customers' businesses better. - Get detailed information and financial and strategic analysis on companies operating in your industry. - Identify prospective partners and suppliers ' with key data on their businesses and locations. - Capitalize on competitor's weaknesses and target the market opportunities available to them. - Compare your company's financial trends with those of your peers / competitors. - Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance. Genentech, Inc. - Financial and Strategic Analysis Review Page 1/5
  • 2. Find Industry reports, Company profiles ReportLinker and Market Statistics Table of Content Table Of Contents Table Of Contents 2 List of Tables 3 List of Figures 3 Genentech, Inc. - Key Facts 4 Genentech, Inc. - Business Description 4 Genentech, Inc. - Major Products and Services 5 Genentech, Inc. - History 6 Genentech, Inc. - SWOT Analysis 8 SWOT Analysis - Overview 8 Genentech, Inc. - Strengths 8 Strength - Expanding Operating Margin 8 Strength - Strong Liquidity Position 8 Strength - Increased Product Sales 8 Strength - Sturdy Research and Development Activities 8 Strength - Performance of Oncology Products 8 Strength - Patent Protection on Key Products 8 Genentech, Inc. - Weaknesses 8 Weakness - Concentrated Revenues 8 Weakness - Limited Customer Base 9 Genentech, Inc. - Opportunities 9 Opportunity - Product Pipeline 9 Opportunity - Growing Global Oncology Market 9 Opportunity - Emerging Markets 9 Opportunity - Rising Healthcare Expenditure in the US 9 Opportunity - Changing Demographics 9 Genentech, Inc. - Threats 10 Threat - Generic Cancer Drugs 10 Threat - Industry Consolidation 10 Threat - Tightening of the FDA's Regulatory Oversight 10 Threat - Increased Pricing Control 10 Genentech, Inc. - Key Competitors 11 Genentech, Inc. - Key Employees 11 Genentech, Inc. - Key Employee Biographies 12 Genentech, Inc. - Company Statement 13 Genentech, Inc. - Locations And Subsidiaries 15 Head Office 15 Other Locations & Subsidiaries 15 Genentech, Inc. - Financial Ratios 16 Financial Ratios - Capital Market Ratios 16 Financial Ratios - Annual Ratios 16 Financial Ratios - Interim Ratios 17 Genentech, Inc. - Financial and Strategic Analysis Review Page 2/5
  • 3. Find Industry reports, Company profiles ReportLinker and Market Statistics Financial Ratios - Ratio Charts 18 Appendix 19 Methodology 19 Ratio Definitions 19 About Global Markets Direct 22 Contact Us 22 Disclaimer 22 List of Tables Genentech, Inc., Key Facts 4 Genentech, Inc., Major Products and Services 5 Genentech, Inc., History 6 Genentech, Inc., Key Employees 11 Genentech, Inc., Key Employee Biographies 12 Genentech, Inc., Other Locations 15 Genentech, Inc., Ratios based on current share price 16 Genentech, Inc., Annual Ratios 16 Genentech, Inc., Interim Ratios 17 List of Figures Genentech, Inc., Ratio Charts 18 Genentech, Inc. - Financial and Strategic Analysis Review Page 3/5
  • 4. Find Industry reports, Company profiles ReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Genentech, Inc. - Financial and Strategic Analysis Review Product Formats Please select the product formats and the quantity you require. Digital Copy--USD 125.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________ Genentech, Inc. - Financial and Strategic Analysis Review Page 4/5
  • 5. Find Industry reports, Company profiles ReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 Genentech, Inc. - Financial and Strategic Analysis Review Page 5/5